165 related articles for article (PubMed ID: 16825028)
1. Body composition and cardiovascular risk in hemodialysis patients.
Nishizawa Y; Shoji T; Ishimura E
J Ren Nutr; 2006 Jul; 16(3):241-4. PubMed ID: 16825028
[TBL] [Abstract][Full Text] [Related]
2. Altered relationship between body fat and plasma adiponectin in end-stage renal disease.
Shoji T; Shinohara K; Hatsuda S; Kimoto E; Fukumoto S; Emoto M; Tahara H; Koyama H; Ishimura E; Miki T; Tabata T; Nishizawa Y
Metabolism; 2005 Mar; 54(3):330-4. PubMed ID: 15736110
[TBL] [Abstract][Full Text] [Related]
3. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
[TBL] [Abstract][Full Text] [Related]
4. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
[TBL] [Abstract][Full Text] [Related]
5. Body mass index, muscle and fat in chronic kidney disease: questions about survival.
Mafra D; Guebre-Egziabher F; Fouque D
Nephrol Dial Transplant; 2008 Aug; 23(8):2461-6. PubMed ID: 18390566
[TBL] [Abstract][Full Text] [Related]
6. Estimation of adipose pools in hemodialysis patients from anthropometric measures.
Kaysen GA; Kotanko P; Zhu F; Sarkar SR; Heymsfield SB; Kuhlmann MK; Levin NW
J Ren Nutr; 2008 Nov; 18(6):473-8. PubMed ID: 18940649
[TBL] [Abstract][Full Text] [Related]
7. Is a body mass index of 23 kg/m² a reliable marker of protein-energy wasting in hemodialysis patients?
Leal VO; Moraes C; Stockler-Pinto MB; Lobo JC; Farage NE; Velarde LG; Fouque D; Mafra D
Nutrition; 2012 Oct; 28(10):973-7. PubMed ID: 22503532
[TBL] [Abstract][Full Text] [Related]
8. Body fat mass in hemodialysis patients.
Ishimura E; Okuno S; Marukawa T; Katoh Y; Hiranaka T; Yamakawa T; Morii H; Kim M; Matsumoto N; Shoji T; Inaba M; Nakatani T; Nishizawa Y
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S137-41. PubMed ID: 12612971
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients.
Yang FL; Lee RP; Wang CH; Fang TC; Hsu BG
Ren Fail; 2007; 29(8):997-1001. PubMed ID: 18067047
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
11. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
Chan MR; Young HN; Becker YT; Yevzlin AS
Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
[TBL] [Abstract][Full Text] [Related]
12. Obesity in renal failure--health or disease?
Stolic R
Med Hypotheses; 2010 Dec; 75(6):497-500. PubMed ID: 20656410
[TBL] [Abstract][Full Text] [Related]
13. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
[TBL] [Abstract][Full Text] [Related]
14. [Obesity in dialysis and reverse epidemiology: true or false?].
Panzetta G; Abaterusso C
G Ital Nefrol; 2010; 27(6):629-38. PubMed ID: 21132645
[TBL] [Abstract][Full Text] [Related]
15. [Body mass index and cardiovascular events: the "obesity paradox"].
Andreotti F; Rio T; Lavorgna A; Coluzzi G; Santucci E; Cecchetti S; Pennestrì F; Crea F
Recenti Prog Med; 2009 Oct; 100(10):447-50. PubMed ID: 20030166
[TBL] [Abstract][Full Text] [Related]
16. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
17. Reverse epidemiology, obesity and mortality in chronic kidney disease: modelling mortality expectations using energetics.
Speakman JR; Westerterp KR
Blood Purif; 2010; 29(2):150-7. PubMed ID: 20093821
[TBL] [Abstract][Full Text] [Related]
18. Body fat measurement in chronic kidney disease: implications in research and clinical practice.
Shoji T; Ishimura E; Nishizawa Y
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):572-6. PubMed ID: 18089973
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin, insulin resistance, and body fat after renal transplantation.
Souza GC; Costa C; Scalco R; Gonçalves LF; Manfro RC
J Ren Nutr; 2008 Nov; 18(6):479-88. PubMed ID: 18940650
[TBL] [Abstract][Full Text] [Related]
20. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
